Strategy to Prevent the Onset of Clinically-Apparent Rheumatoid Arthritis
Public ClinicalTrials.gov record NCT02603146. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Study identification
- NCT ID
- NCT02603146
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- NIH
- Enrollment
- 144 participants
Conditions and interventions
Interventions
- Hydroxychloroquine Drug
- HCQ Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 26, 2016
- Primary completion
- Oct 31, 2022
- Completion
- Oct 31, 2022
- Last update posted
- Jun 11, 2025
2016 – 2022
United States locations
- U.S. sites
- 14
- U.S. states
- 11
- U.S. cities
- 13
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Alabama at Birmingham School of Medicine: Division of Clinical Immunology & Rheumatology | Birmingham | Alabama | 35294 | — |
| Cedars Sinai Medical Center: Division of Rheumatology | Los Angeles | California | 90048 | — |
| UCLA Medical Center: Division of Rheumatology | Los Angeles | California | 90095 | — |
| University of California San Francisco, San Francisco General Hospital | San Francisco | California | 94110 | — |
| University of Colorado School of Medicine: Division of Rheumatology | Aurora | Colorado | 80045 | — |
| Emory Clinic at 1365 Clifton Road: Emory University School of Medicine | Atlanta | Georgia | 30322 | — |
| Brigham & Women's Hospital: Department of Medicine, Rheumatology, Immunology | Boston | Massachusetts | 02115 | — |
| University of Massachusetts Memorial Medical Center: Rheumatology | Worcester | Massachusetts | 01605 | — |
| University of Michigan Health System: Department of Internal Medicine, Division of Rheumatology | Ann Arbor | Michigan | 48109 | — |
| Mayo Clinic, Division of Rheumatology | Rochester | Minnesota | 55905 | — |
| University of Nebraska Medical Center: Division of Rheumatology | Omaha | Nebraska | 68198 | — |
| Northwell Health | Great Neck | New York | 110211 | — |
| Oklahoma Medical Research Foundation: Arthritis and Clinical Immunology Research Program | Oklahoma City | Oklahoma | 73104 | — |
| University of Texas Southwestern Medical Center, Division of Rheumatic Diseases | Dallas | Texas | 75390 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02603146, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 11, 2025 · Synced Jul 24, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02603146 live on ClinicalTrials.gov.